Literature DB >> 4633977

Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.

W R Sanborn, Z Bencić, B Cvjetanović, E C Gotschlich, T M Pollock, J E Sippel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4633977

Source DB:  PubMed          Journal:  Prog Immunobiol Stand        ISSN: 0079-6344


× No keyword cloud information.
  6 in total

1.  Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.

Authors:  Zhigang Jin; Gregory A Bohach; Joseph Shiloach; Scott E Norris; Darón I Freedberg; Claudia Deobald; Bruce Coxon; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Vaccine Development and Collaborations: Lessons from the History of the Meningococcal A Vaccine (1969-73).

Authors:  Baptiste Baylac-Paouly
Journal:  Med Hist       Date:  2019-10       Impact factor: 1.419

Review 3.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

4.  Homogeneity of protein serotype antigens in Neisseria meningitidis group A.

Authors:  J E Sippel; A Quan
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.

Authors:  H H Erwa; M A Haseeb; A A Idris; L Lapeyssonnie; W R Sanborn; J E Sippel
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

6.  Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.

Authors:  L V Cooper; P A Kristiansen; H Christensen; A Karachaliou; C L Trotter
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.